Načítá se...
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy
The landscape of idiopathic pulmonary fibrosis (IPF) has changed. The significant progress regarding our knowledge on the pathogenesis of the disease together with the experience achieved after a series of negative trials has led to the development of two drugs for the treatment of IPF. Both pirfeni...
Uloženo v:
| Vydáno v: | Core Evid |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4936814/ https://ncbi.nlm.nih.gov/pubmed/27445644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S76549 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|